🏠 Home / By Experiment / Immunotherapy/Cell Therapy / Vaccine Development 中文 EN
💉 Immunotherapy/Cell Therapy · Method

Vaccine Development

Design and validate vaccine immunogenicity
🎯 Difficulty ★★★ Advanced Duration About 2–6 weeks 🎯 Use Design antigens and evaluate vaccine immunogenicity and protective efficacy
📖 Principle
Immunize animals with antigen and adjuvant, measure specific antibody and cellular responses, assess protection
Below are 4 steps. Open each to see how to do it and add products to your shared list.

📋 Workflow

Full workflow, products add-to-cart directly
1

Antigen and adjuvant formulation

1 h
Select/prepare antigen and mix with adjuvant at ratio, emulsify to form vaccine
💡 Tip Adjuvant boosts immunogenicity
⚠️ Caution Emulsify fully for stable formulation
🧪 Materials for this step (click to shop by spec/brand)
2

Animal immunization

2–6 weeks
Immunize animals per schedule several times, collect blood to assess antibody response
💡 Tip Optimize schedule and dose
⚠️ Caution Follow ethical guidelines
🧪 Materials for this step (click to shop by spec/brand)
3

Immunogenicity evaluation

1–2 days
Measure antibody titer by ELISA, evaluate T-cell response by ELISpot/flow and neutralizing activity
💡 Tip Neutralizing antibody is a key correlate
⚠️ Caution Integrate multiple readouts
🧪 Materials for this step (click to shop by spec/brand)
4

Efficacy evaluation

2–4 weeks
Assess protective efficacy and safety by challenge or animal model
💡 Tip Include placebo and challenge controls
⚠️ Caution Monitor safety equally
🧪 Materials for this step (click to shop by spec/brand)

⚠️ 5 Common Beginner Mistakes

  • Wrong adjuvant gives poor immunogenicity
  • Antigen purity/stability issues
  • Poor schedule weakens response
  • Single-metric evaluation biases
  • No control undermines efficacy

❓ FAQ

+What does antibody titer reflect?
Reflects vaccine-induced specific antibody; neutralizing titer correlates better with protection.
+How to assess T-cell responses?
Use ELISpot for IFN-secreting T cells or flow for intracellular cytokines.
+What challenge for efficacy?
Challenge with relevant pathogen/model and compare survival/disease between vaccine and control.

🧾 My Cart

Items selected on the product page are shared here
Nothing added yet
🛒 Go to Products
Data authenticity: Product categories from JW Supply Chain standard taxonomy; method→step→product connected. Last updated: 2026-08-23 · v3.0